What is the level of liabilities of Brainsway this year?
Brainsway has a debt balance of 21.39 M USD this year.
Brainsway Liabilities 2024
Brainsway Liabilities
21.39 M USD
Ticker
BWAY.TA
ISIN
IL0011007189
WKN
A0NDVW
In 2024, Brainsway's total liabilities amounted to 21.39 M USD, a 12.11% difference from the 19.08 M USD total liabilities in the previous year.
Brainsway Aktienanalyse
What does Brainsway do?
Brainsway Ltd is a leading provider of non-invasive brain stimulation solutions based in Jerusalem, Israel. The company was founded in 2003 and has since become a major player in the field of neurological disorders. Brainsway's business model includes the development, production, and marketing of innovative brain stimulation solutions. The company's products are based on transcranial magnetic stimulation (TMS), a proven technology for treating neurological disorders. TMS involves generating brain stimulation through a non-invasive method, using gentle magnetic pulses directed at the targeted area of the brain to specifically influence brain activity. The company is divided into three business areas: psychiatry, neurology, and rehabilitation. The psychiatry area includes the treatment of disorders such as depression, obsessive-compulsive disorder, addiction, and schizophrenia. The neurology area, on the other hand, focuses on disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. The rehabilitation area is used for anatomical rehabilitation and stroke rehabilitation and is the newest product of Brainsway. Each area includes a variety of products tailored to the individual needs of users. One of Brainsway's most well-known products is the Deep TMS Stimulator, which was specifically developed for the treatment of depression. The Deep TMS therapy has been clinically tested and identified as an effective method for treating depression, obsessive-compulsive disorder, and ADHD. The device has already been marketed in over twenty countries. Brainsway is also a leader in the treatment of Parkinson's disease with TMS. Clinical studies have shown that the application of Brainsway TMS in Parkinson's patients reduces symptoms by almost 50%. The benefits of TMS in Parkinson's include improved motor function, increased quality of life, and a reduction in the frequency of falls. The company has established collaborations with major pharmaceutical companies and research institutions. Brainsway works closely with scientific institutions to continuously develop and improve therapies and products. Brainsway Ltd is an innovative company that is a leader in the field of non-invasive brain stimulation. Brainsway's products have proven to be effective in treating a variety of disorders, and the company has a promising future in researching and developing new therapies. Brainsway ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Brainsway's Liabilities
Brainsway's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Brainsway's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Brainsway's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Brainsway's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Brainsway’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Brainsway stock
What were the liabilities of Brainsway compared to the previous year?
The liabilities of Brainsway have increased by 12.11% increased compared to the previous year.
What are the consequences of high debt for investors of Brainsway?
High liabilities can pose a risk for investors of Brainsway, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Brainsway?
Low liabilities mean that Brainsway has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Brainsway affect the company?
An increase in liabilities of Brainsway can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Brainsway affect the company?
A decrease in the liabilities of Brainsway can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Brainsway?
Some factors that can influence the liabilities of Brainsway include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Brainsway so important for investors?
The liabilities of Brainsway are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Brainsway take to modify the liabilities?
To change its liabilities, Brainsway can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Brainsway pay?
Over the past 12 months, Brainsway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Brainsway is expected to pay a dividend of 0 USD.
What is the dividend yield of Brainsway?
The current dividend yield of Brainsway is .
When does Brainsway pay dividends?
Brainsway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Brainsway?
Brainsway paid dividends every year for the past 0 years.
What is the dividend of Brainsway?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Brainsway located?
Brainsway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Brainsway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Brainsway from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did Brainsway pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of Brainsway in the year 2023?
In the year 2023, Brainsway distributed 0 USD as dividends.
In which currency does Brainsway pay out the dividend?
The dividends of Brainsway are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Brainsway
Our stock analysis for Brainsway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Brainsway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
